CVE-2015-3965
CVSS2
Attack Vector
NETWORK
Attack Complexity
LOW
Authentication
SINGLE
Confidentiality Impact
COMPLETE
Integrity Impact
COMPLETE
Availability Impact
COMPLETE
AV:N/AC:L/Au:S/C:C/I:C/A:C
CVSS3
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
HIGH
Integrity Impact
HIGH
Availability Impact
HIGH
CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
AI Score
Confidence
High
EPSS
Percentile
58.9%
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger “unanticipated operations” by leveraging “elevated privileges” for an unspecified call to an incorrectly exposed function.
Affected configurations
| Vendor | Product | Version | CPE |
|---|---|---|---|
| pfizer | symbiq_infusion_system_firmware | * | cpe:2.3:o:pfizer:symbiq_infusion_system_firmware:*:*:*:*:*:*:*:* |
| pfizer | symbiq_infusion_system | - | cpe:2.3:h:pfizer:symbiq_infusion_system:-:*:*:*:*:*:*:* |
Related
CVSS2
Attack Vector
NETWORK
Attack Complexity
LOW
Authentication
SINGLE
Confidentiality Impact
COMPLETE
Integrity Impact
COMPLETE
Availability Impact
COMPLETE
AV:N/AC:L/Au:S/C:C/I:C/A:C
CVSS3
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
HIGH
Integrity Impact
HIGH
Availability Impact
HIGH
CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
AI Score
Confidence
High
EPSS
Percentile
58.9%